Newtopia Inc
XTSX:NEWU
Intrinsic Value
Newtopia, Inc. is a health technology company, which engages in the development and delivery of disease prevention solutions. [ Read More ]
The intrinsic value of one NEWU stock under the Base Case scenario is 0.14 CAD. Compared to the current market price of 0.07 CAD, Newtopia Inc is Undervalued by 50%.
Valuation Backtest
Newtopia Inc
Run backtest to discover the historical profit from buying and selling NEWU stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Newtopia Inc
Current Assets | 2.8m |
Cash & Short-Term Investments | 575.6k |
Receivables | 1.8m |
Other Current Assets | 443k |
Non-Current Assets | 2.6m |
PP&E | 5.6k |
Intangibles | 2.6m |
Other Non-Current Assets | -10 |
Current Liabilities | 9m |
Accounts Payable | 1.9m |
Short-Term Debt | 6.9m |
Other Current Liabilities | 154.7k |
Non-Current Liabilities | 2.8m |
Long-Term Debt | 2.8m |
Earnings Waterfall
Newtopia Inc
Revenue
|
10.6m
CAD
|
Cost of Revenue
|
-4.6m
CAD
|
Gross Profit
|
6m
CAD
|
Operating Expenses
|
-9.3m
CAD
|
Operating Income
|
-3.3m
CAD
|
Other Expenses
|
-1.6m
CAD
|
Net Income
|
-5m
CAD
|
Free Cash Flow Analysis
Newtopia Inc
What is Free Cash Flow?
NEWU Profitability Score
Profitability Due Diligence
Newtopia Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Newtopia Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
NEWU Solvency Score
Solvency Due Diligence
Newtopia Inc's solvency score is 20/100. The higher the solvency score, the more solvent the company is.
Score
Newtopia Inc's solvency score is 20/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NEWU Price Targets Summary
Newtopia Inc
According to Wall Street analysts, the average 1-year price target for NEWU is 0.4 CAD .
Shareholder Return
NEWU Price
Newtopia Inc
Average Annual Return | -34.51% |
Standard Deviation of Annual Returns | 46.99% |
Max Drawdown | -98% |
Market Capitalization | 11.1m CAD |
Shares Outstanding | 158 335 300 |
Percentage of Shares Shorted | 0.01% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Newtopia, Inc. is a health technology company, which engages in the development and delivery of disease prevention solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-05-04. The firm provides disease prevention solutions by leveraging technology, behavioral science and genetics to help individuals prevent chronic diseases. The firm's Newtopia platform leverages precision health tools including, genetic testing and behavioral evaluations, to develop and implement personalized experiences combining the human intervention with the digital interaction. The company partners with insurers and employers and focuses its efforts on employees or members at risk of developing chronic diseases, including but not limited to obesity, type two diabetes, heart disease, stroke or fatty liver disease. Its personalized program focuses to manage five primary metabolic risk factors of chronic disease, including body mass index (BMI), blood pressure, blood glucose, triglycerides and cholesterol. In addition to its solution for lowering risk for metabolic syndrome, the Company also delivers individualized support.
Contact
IPO
Employees
Officers
The intrinsic value of one NEWU stock under the Base Case scenario is 0.14 CAD.
Compared to the current market price of 0.07 CAD, Newtopia Inc is Undervalued by 50%.